Unibest

Pharmaceutical intermediates

Imeglimin hydrochloride Intermediates

1 pharmaceutical intermediate for Imeglimin hydrochloride. Indication: Type 2 diabetes mellitus.

Submit a ProjectAll intermediates

About Imeglimin hydrochloride

Originator
Merck Kgaa
Indication
Type 2 diabetes mellitus
Approved Date
06/23/2021

Available intermediates

1 intermediate currently listed for Imeglimin hydrochloride. Request specifications, documentation or a quotation for any item below.

Imeglimin hydrochloride intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
N-VINYLFORMAMIDE13162-05-5//

Other programs under I

Ibrutinib/ Zanubrutinib IguratimodImatinibIndacaterol MaleateInfigratinibIpatacopan HydrochlorideIpragliflozinIrinotecan

Building toward Imeglimin hydrochloride?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →